Use of biologics to treat relapsing and/or refractory polyarteritis nodosa: data from a European collaborative study

Hadjadj J., Canzian A., KARADAĞ Ö., Contis A., Maurier F., Sanges S., ...More

RHEUMATOLOGY, vol.62, pp.341-346, 2022 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 62
  • Publication Date: 2022
  • Doi Number: 10.1093/rheumatology/keac332
  • Journal Name: RHEUMATOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, CINAHL, EMBASE, International Pharmaceutical Abstracts, MEDLINE
  • Page Numbers: pp.341-346
  • Keywords: Polyarteritis nodosa, biologics, tocilizumab, rituximab, TNF-alpha, blocker, SYSTEMIC-NECROTIZING-VASCULITIDES, MANAGEMENT
  • Hacettepe University Affiliated: Yes


Objectives. To describe the effectiveness and safety of biologics for the treatment of relapsing and/or refractory polyarteritis nodosa (PAN).